Table 2 Characterization of articles included which study molecular deletions on pfhrp2/3
First author | Country | Samples’ year | Collection season | Study population | Methodologies |
|---|---|---|---|---|---|
Abdallah [19] | Honduras | 2008–09 | Both or annual | Malaria confirmed field samples | PCR, SSR/STR |
Okoth [39] | Suriname and Guyana | 2010–11 | High transmission | Malaria confirmed field samples | PCR, SSR/STR |
Akinyi [57] | Peru | 1998–05 | High transmission | Malaria confirmed field samples | PCR, SSR/STR |
Amoah [74] | Ghana | 2014–15 | Low transmission | Population sampling among children, asymptomatic | PCR |
Atroosh [48] | Yemen | 2012 | High transmission | Population sampling among all ages, symptomatic | PCR, Seq |
Baker [15] | 18 countriesa | 2010 | Not reported | Malaria confirmed field samples | PCR, Seq |
Baldeviano [59] | Peru | 2010–12 | Malaria outbreak | Malaria confirmed samples among symptomatic patients at health centre | PCR, SSR/STR |
Berhane [14] | Eritrea | 2016 | High transmission | Population sampling among all ages, from health centre | PCR, SSR/STR |
Berzosa [21] | Equatorial Guinea | 2013 | Both or annual | Population sampling among all ages | PCR, Seq., SSR/STR |
Beshir [49] | Kenya | 2007–08 and 2014 | Not reported | Population sampling among symptomatic at health centre and among children Asymptomatic | PCR, Seq |
Bharti [24] | India | 2014 | High transmission | Population sampling among all ages, symptomatic | PCR, Seq |
Deme [38] | Senegal, Mali and Uganda | 2001–10 | High transmission | Malaria confirmed field samples, from health centre | Seq., SSR/STR |
Dong [58] | China | 2013–18 | Both or annual | Population sampling among all ages, symptomatic | PCR, Seq., SSR/STR |
Dorado [20] | Colombia | 2003–12 | Not reported | Malaria confirmed field samples | PCR, Seq., SSR/STR |
Fontecha [41] | Honduras Guatemala and Nicaragua | 2011 and 2015 | Not reported | Malaria confirmed field samples | PCR |
Funwei [69] | Nigeria | 2013–14 | Both or annual | Population sampling among children, Symptomatic | PCR, Seq |
Gamboa [18] | Peru | 2003–07 and 2007 | Not reported | Malaria confirmed field samples from health facility and population sampling among symptomatic (active case detection) | PCR, Seq., ELISA |
Gupta [22] | Mozambique | 2010–16 | Both or annual | Population sampling among all ages | PCR |
Herman [43] | Haiti | 2012–14 | Both or annual | Population sampling among all ages, symptomatic | PCR |
Kobayashi [52] | Zambia | 2009–11 and 2015–17 | High transmission | Population sampling among all ages | PCR |
Koita [28] | Mali | 1996 | High transmission | Population sampling among all ages and children asymptomatic | PCR |
Kozycki [11] | Ruanda | 2014–15 | Both or annual | Population sampling among all ages, symptomatic at health centre | PCR |
Kreidenweiss [55] | Gabon | 2017–18 | Both or annual | Lab strains and clinical sample | PCR, Seq |
Kumar Bharti [71] | India | 2014 | Both or annual | Malaria confirmed field samples | PCR, Seq |
Kumar [42] | India | 2010 | Both or annual | Malaria confirmed field samples | PCR |
Kumar [50] | India | 2009–11 | Both or annual | Malaria confirmed field samples | PCR, Seq |
Laban [54] | Zambia | 2008–12 | Both or annual | Population sampling among all ages | PCR |
Li [45] | China | 2011–12 | Both or annual | Malaria confirmed field samples | PCR, Seq |
Maltha [13] | Peru | 2010–11 | Both or annual | Malaria confirmed field samples, from health centre | PCR |
Menegon [23] | Eritrea | 2013–14 | Not reported | Population sampling among all ages | PCR |
Murillo-Solano [63] | Colombia | 1999–09 | Both or annual | Malaria confirmed field samples | PCR, SSR/STR |
Mussa [61] | Sudan | Not reported | Not reported | Population sampling among all ages, symptomatic | PCR, Seq |
Nderu [9] | Kenya | 2007–16 | Not reported | Malaria confirmed field samples, from symptomatic patients | PCR, Seq |
Nderu [60] | Kenya | 2016 | Both or annual | Malaria confirmed field samples from symptomatic patients | PCR, Seq., SSR/STR |
Okoth [44] | Peru | 2013 | Malaria outbreak | Malaria confirmed field samples from symptomatic patients | PCR, SSR/STR |
Owusu [47] | Ghana | 2015 | Both or annual | Population sampling among children, HIV positives and healthy | PCR |
Parr [46] | D.R. of Congo | 2013–2014 | Both or annual | Population sampling among children, majority asymptomatic | PCR, SSR/STR |
Pati [25] | India | 2013–16 | Both or annual | Population sampling among all ages, symptomatic | PCR, Seq |
Plucinski [51] | Angola | 2016 | High transmission | Population sampling among all ages, at health centre | PCR |
Rachid Viana [40] | Brazil and Bolivia | 2010–12 | Not reported | Malaria confirmed field samples, at health centre | PCR |
Ramutton [37] | 7 countriesb | 2005–10 | Not reported | Population sampling among children with severe malaria | PCR, Seq |
Ranadive [53] | Swaziland | 2012–15 | Both or annual | Population sampling among all ages, symptomatic | PCR |
Sáenz [56] | Ecuador | 2012–13 | Both or annual | Malaria confirmed field samples | |
Thomson [12] | Ghana Tanzania and Uganda | 2009–10 and 2014–15 | High transmission | Malaria confirmed field samples from symptomatic population with all ages, at health facilities and national survey | PCR |
Trouvay [73] | French Guiana | 2009 and 2011 | Both or annual | Malaria confirmed field samples | PCR, Seq., SSR/STR |
Willie [30] | Papua New Guinea | 2001–03 | Both or annual | Population sampling among all ages | PCR, Seq |
Willie [62] | Madagascar | 2014–15 | Both or annual | Population sampling among all ages, mostly asymptomatic | PCR, Seq |
Wurtz [16] | Senegal | 2009–11 | High transmission | Malaria confirmed field samples, at health centre | PCR, Seq |